Works matching IS 22351795 AND DT 2022 AND VI 11 AND IP 5
Results: 9
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 1, doi. 10.1159/000526882
- Publication type:
- Article
Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 399, doi. 10.1159/000526163
- By:
- Publication type:
- Article
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 426, doi. 10.1159/000525582
- By:
- Publication type:
- Article
Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 407, doi. 10.1159/000524893
- By:
- Publication type:
- Article
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 460, doi. 10.1159/000525488
- By:
- Publication type:
- Article
Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 474, doi. 10.1159/000525346
- By:
- Publication type:
- Article
Regarding "Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study".
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 483, doi. 10.1159/000525065
- By:
- Publication type:
- Article
Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 440, doi. 10.1159/000525500
- By:
- Publication type:
- Article
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 451, doi. 10.1159/000525489
- By:
- Publication type:
- Article